At the Dutch Medicines Days (DMD), the Galen awards have been presented. Led by a jury, these awards are presented anually to one researcher and one drug that is the most innovative and meaningful. This year’s best researcher was Tom Würdinger, PhD of the neuro-oncology group at the VUmc, Amsterdam. The award for the best drug went to Kalydeco from Vertex, a compound indicated for cystic fibrosis (CF). Continue reading
Showing articles tagged with 'Figon'
This year, the Dutch Medicines Days 2014 (DMD) were predominated by the subject of personalised medicine. Medical doctors, researchers and delegates from insurance providers and pharmaceutical companies discussed implementation and innovative treatment methods considering this subject. The DMD is a congress on innovative drug research, hosted by the Federation for Innovative Drug Research in the Netherlands (FIGON). Continue reading